Frost took a very large position in an asset transfer with RXI Pharmaceuticals, All of OPK's RNAi assets were transferred to RXI in the deal. In fact RXI is the first company to have human trials with RNAi compound.
Too much to go over, been in this stock over two years, looks very promising for their anti scarring drug rxi-109, no present drug available for anti scarring, planned surgeries alone est. $4B market. Beginning 3 Ph2 trials this fall and they are timely due to the nature of skin healing the trials are short timewise.
Frost's large position here ( coupled with his background in dermatology ), was based in his thinking IMHO, that rxi-109 looks very promising, especially after stellar Ph1 results.
Worth a good look, changing over to nasdaq from otcqx any day now....good luck All
Thanks for your input. I just did a brief look into RXII and it seems interesting enough. However, they had to do a 1 for 30 reverse split to be eligible for NASDAQ and there seems to be some concerns about warrants, but the up listing should provide a bump for sure and there has been a quite a bit of insider buying in August, so you are right and it probably needs further research. Thanks.
Yes the Russian main guy was at the meeting. Dimitri. No last name. I don't like dealing with Russia but I think PF said the govt was putting in $30 million. I'm half Russian so dont jump on me please. Dimitri is a lawyer who introduced them to a biotech Opko is working with. They are all about preventing transplanted organ rejection if I Heard correctly and then Opko can also distribute their products.
I'd like to get behind one maybe two traded companies that has potential to be acquired, but the Dr and Opko has investments in so many. I know some like SFES, but NIMU makes sense too. PFSCF.PK just went public a couple months ago with the guidance of LTS, but that is very speculative.